NFκB activation has been observed in numerous GI-related conditions including inflammatory bowel disease [47], Crohn's disease [48], ulcerative colitis [35], inflamed intestinal mucosa [49] as well as CRC [50-53]. The gene discussed is NFKB1; the disease is colorectal carcinoma.